Quince Therapeutics, Inc. (QNCX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
31,529,000
EV to revenue ratio (TTM)
EV to ebitda
1.438
Financial Performance
Revenue (TTM)
0
Gross profit (TTM)
0
EBITDA
-60,647,000
Profitability
Operating margin (TTM)
0.00%
Profit margin
0.00%
Return on assets (TTM)
-31.50%
Return on equity (TTM)
-153.80%
Per Share Metrics
Revenue per share (TTM)
0
EPS
-210.84
Diluted EPS (TTM)
-210.84
Book value
-34.73
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
Price to book ratio (TTM)
2.209
Growth
Quarterly earnings growth (YoY)
0.00%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
0
Buy
5
Hold
2
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.309